Bruno Sepodes
Overview
Explore the profile of Bruno Sepodes including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
71
Citations
1107
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Monteiro J, Almeida D, Fernandes J, Sepodes B, Torre C
Expert Opin Drug Saf
. 2025 Feb;
:1-12.
PMID: 39989100
Background: Risk management in oncology is critical due to toxicity, narrow therapeutic windows, and strict dosing schedules. This study analyzed post-authorization studies from the HMA-EMA Real-World Data Catalogues evaluating the...
2.
Windfuhr F, de Vries S, Melinder M, Dahlqvist T, Almeida D, Sepodes B, et al.
Drug Saf
. 2025 Feb;
PMID: 39987538
Background: The use of patient registries in regulatory, health technology assessment (HTA), and payer decision-making has gained increasing attention in recent years. Stakeholders' perspectives toward the use of registry-based real-world...
3.
Arlett P, Umuhire D, Verpillat P, Foggi P, Wandel Liminga U, Sepodes B, et al.
Clin Pharmacol Ther
. 2025 Feb;
PMID: 39949283
No abstract available.
4.
Mandslay D, Almeida D, Marques A, Rocha J, Drafi F, Sepodes B, et al.
Clin Pharmacol Ther
. 2024 Aug;
117(1):73-93.
PMID: 39140780
In the current landscape, regulatory agencies face the challenge of reconciling timely authorizations for novel medicines addressing life-threatening conditions with thorough evaluations of their benefits and risks. This challenge is...
5.
Almeida D, Rodrigues A, Guerreiro J, Balkowiec-Iskra E, Vander Stichele R, Sepodes B, et al.
Parasitol Res
. 2024 Jun;
123(6):235.
PMID: 38850458
This study aims to assess the effect of the COVID-19 pandemic on the consumption of self-care products for pediculosis capitis management, in Portugal. A segmented regression analysis of interrupted time...
6.
Almeida D, Umuhire D, Gonzalez-Quevedo R, Antonio A, Burgos J, Verpillat P, et al.
Front Med (Lausanne)
. 2024 Jun;
11:1408636.
PMID: 38846141
Patient experience data (PED), provided by patients/their carers without interpretation by clinicians, directly capture what matters more to patients on their medical condition, treatment and impact of healthcare. PED can...
7.
Buchholz S, Di Meco E, Balkowiec-Iskra E, Sepodes B, Cavaleri M
Nat Med
. 2024 May;
30(8):2109-2110.
PMID: 38806678
No abstract available.
8.
Direito R, Barbalho S, Sepodes B, Figueira M
Pharmaceutics
. 2024 May;
16(5).
PMID: 38794239
There is a growing trend among consumers to seek out natural foods and products with natural ingredients. This shift in consumer preferences had a direct impact on both food and...
9.
Cerreta F, Iskra E, Cupelli A, Sepodes B, Ronnemaa E, Rosa M, et al.
J Am Geriatr Soc
. 2024 May;
72(9):2921-2927.
PMID: 38757979
The European Medicines Agency adopted their Geriatric Medicines Strategy more than a decade ago. The strategy aims at elucidating the evidence basis for marketing authorization of new medicines which will...
10.
Marques A, Cavaco P, Torre C, Sepodes B, Rocha J
Crit Rev Oncol Hematol
. 2024 Apr;
197:104342.
PMID: 38614266
Although immune checkpoint inhibitors have revolutionized the treatment of several advanced solid cancers, in colorectal cancer, the transformative benefit of these innovative medicines is currently limited to those with deficient...